Aquinox Prices Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Canaccord Genuity Raises Price Target on Aquinox Pharma (AQXP) to $22 on Supporting Evidence for AQX-1125
September 11, 2015 9:24 AM EDTCanaccord Genuity reiterated a Buy rating on Aquinox Pharmaceutical (NASDAQ: AQXP), and raised the price target to $22.00 (from $10.00), on supporting evidence for AQX-1125, and ahead of FDA meetings. Aquinox will meet with FDA, on BPS/IC, for an end of P2 meeting in Nov. to finalize two Ph3's, the 1st of which should start by mid-2016.
Analyst... More
Aquinox Pharma (AQXP) 5.5M Offering Common Stock Prices at $15.50/Share
September 10, 2015 9:15 AM EDTAquinox Pharma (NASDAQ: AQXP) announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $15.50 per share. In addition, Aquinox has granted the underwriters a 30-day option to purchase up to 825,000 additional... More



